Compare, Analyse AJANTA PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   ACTAVIS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ACTAVIS
Dec-18
AJANTA PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,42214,176-   
Low Rs8989,509-   
Sales per share (Unadj.) Rs233.53,477.3-  
Earnings per share (Unadj.) Rs44.0-1,120.0-  
Cash flow per share (Unadj.) Rs52.2366.4-  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.114,342.3-  
Shares outstanding (eoy) m88.02332.60-   
Bonus / Rights / Conversions BB--  
Price / Sales ratio x5.03.4 145.8%   
Avg P/E ratio x26.4-10.6 -249.5%  
P/CF ratio (eoy) x22.232.3 68.8%  
Price / Book Value ratio x4.50.8 550.6%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,0813,938,809 2.6%   
No. of employees `0006.816.9 40.2%   
Total wages/salary Rs m4,3070-   
Avg. sales/employee Rs Th3,022.668,435.2 4.4%   
Avg. wages/employee Rs Th633.40-   
Avg. net profit/employee Rs Th569.1-22,043.0 -2.6%   
INCOME DATA
Net Sales Rs m20,5541,156,556 1.8%  
Other income Rs m21122,117 1.0%   
Total revenues Rs m20,7651,178,673 1.8%   
Gross profit Rs m5,66430,308 18.7%  
Depreciation Rs m721494,402 0.1%   
Interest Rs m1266,740 0.0%   
Profit before tax Rs m5,143-508,717 -1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0129,743 0.0%   
Tax Rs m1,273-6,447 -19.7%   
Profit after tax Rs m3,870-372,527 -1.0%  
Gross profit margin %27.62.6 1,051.6%  
Effective tax rate %24.81.3 1,953.3%   
Net profit margin %18.8-32.2 -58.5%  
BALANCE SHEET DATA
Current assets Rs m11,812474,359 2.5%   
Current liabilities Rs m3,776419,633 0.9%   
Net working cap to sales %39.14.7 826.3%  
Current ratio x3.11.1 276.7%  
Inventory Days Days7720 395.1%  
Debtors Days Days8266 123.1%  
Net fixed assets Rs m14,398130,916 11.0%   
Share capital Rs m1750-   
"Free" reserves Rs m22,2770-   
Net worth Rs m22,4524,770,252 0.5%   
Long term debt Rs m71,679,779 0.0%   
Total assets Rs m26,9627,456,989 0.4%  
Interest coverage x444.3-6.6 -6,709.6%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.2 491.5%   
Return on assets %14.4-4.1 -351.1%  
Return on equity %17.2-7.8 -220.7%  
Return on capital %23.0-4.8 -474.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5800-   
CASH FLOW
From Operations Rs m3,748413,194 0.9%  
From Investments Rs m-2,228226,996 -1.0%  
From Financial Activity Rs m-1,475-709,164 0.2%  
Net Cashflow Rs m45-68,630 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.26 Rs / USD

Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: PFIZER  ABBOTT INDIA  FDC  NOVARTIS  SUN PHARMA  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Revealing at 5pm Today: The Great Indian Wealth Project
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AJANTA PHARMA SHARE PRICE


May 17, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA - PIRAMAL ENTERPRISES COMPARISON

COMPARE AJANTA PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS